Rebecca Arden Harris

Rebecca Arden Harris

Auto-generated profile, based on publicly available information

Rebecca Arden Harris

Department of Family Medicine and Community Health, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 June 2008 in Hepatology
Verified
Journal Article
Open access
PDF file
RHRebecca A. Harris
Rebecca A. Harris
KSKazushi Sugimoto
Kazushi Sugimoto
DKDavid Edward Kaplan
David Edward Kaplan
FIFusao Ikeda
Fusao Ikeda
MKMalek Kamoun
Malek Kamoun
KCKyong‐Mi Chang
Kyong‐Mi Chang
The outcome of hepatitis C virus (HCV) infection has been associated with antiviral CD4 T cell response, human leukocyte antigens (HLA) class II genotypes, and ethnicity. However, HLA class II molecules restrict the nature of CD4 T cell response, and HLA distributions differ between ethnic groups. In this study, we asked whether HLA class II genotypes associated with HCV clearance are shared between Caucasian and African Americans and whether they contribute to enhanced antiviral CD4 T cell response. In a cohort of 93 HCV‐seropositive subjects from Northeast America with defined ethnicity, virological outcome, and HCV‐specific CD4 T cell proliferation, we confirm the previously reported associations between HCV clearance and two HLA types (DQB1*03, DRB1*11) while identifying a new association with DRB3*02. Strikingly, these associations were identified only among Caucasian [DQB1*03: odds ratio (OR), 10.4; P = 0.031, DRB1*11: OR, 7.0, P = 0.019; DRB3*02: OR, 8.3, P = 0.005; DQB1*03–DRB3*02: OR, 13.5, P = 0.001) but not among African American patients. Furthermore, although HLA DQB1*03, DRB1*11, and DRB3*02 genotypes were associated with increased HCV‐specific CD4 T cell response in univariate analyses, these associations were lost when controlling for virological outcomes. Conclusion: We conclude that the immunogenetic basis for HCV clearance differs between ethnic groups and that the association between HLA class II and HCV clearance is not directly explained by antiviral CD4 T cell response. (HEPATOLOGY 2008.)

22 December 2022 in AJPM Focus
Verified
Journal Article
Open access
RHRebecca Arden Harris
Rebecca Arden Harris
Fatal drug overdoses have risen sharply in the U.S. since 2015, reaching their highest levels during the pandemic. Non-Hispanic Black men have been disproportionately harmed by this latest surge; overdose mortality per 100,000 has increased fourfold since 2015. Whether the mortality rate will continue to climb is unknown. In this study, we addressed the narrower question of which age groups are likely to experience a significant increase or decrease in the burden of drug overdose deaths through 2025, based on foreseeable changes in the age structure of the Black male population. We used the 2020 and provisional 2021 age-specific mortality rates from the Centers for Disease Control WONDER (Wide-Ranging Online Data for Epidemiologic Research) database and the standard population balancing equation to project overdose deaths in 2025. Overdose deaths were identified by ICD-10 codes. We bracketed the projections between 2 plausible alternatives: a pessimistic forecast based on time series extrapolations and an optimistic forecast that assumes success nationally in lowering overdose deaths through prevention, treatment, and harm reduction initiatives. Among Black men aged 31-47 years, overdose deaths in 2025 are expected to increase by 440 or 11% (95% CI=8%, 14%) relative to 2020. By contrast, overdose deaths among younger Black men aged 19-30 years are expected to decline by 160 or -9% (95% CI= -15%, -5%). Among older Black men aged 48-64 years, overdose deaths are also expected to decline by 330 or -7% (95% CI= -10%, -4%). Similar results were found using 2021 provisional mortality rates. Overdose deaths are predicted to increase significantly over current levels among Black men in their 30s and 40s. Local policy makers should direct harm reduction resources, such as naloxone kits, syringes, and fentanyl test strips, to places frequented by Black men in this age group. Outreach messaging should be tailored to resonate with men of middle age. Equally urgent is the scaling up of nonstigmatizing, evidence-based drug treatment and recovery support services in Black neighborhoods.

1 March 2017 in JAIDS Journal of Acquired Immune Deficiency Syndromes
Verified
Journal Article
Open access
RHRebecca Arden Harris
Rebecca Arden Harris
XXXiaonan Xue
Xiaonan Xue
PSPeter A. Selwyn
Peter A. Selwyn
Background: Previous research has produced inconsistent evidence of an association between housing stability and medication adherence among HIV-positive individuals in antiretroviral therapy. Objective: We conducted a meta-analysis of the housing–adherence relationship based on a comprehensive search of observational studies in the PubMed, Embase, and Cochrane databases (January 2000–January 2016). Ten qualifying studies were identified representing 10,556 individuals. Methods: A random-effects model was used to estimate the overall effect size and 95% confidence interval (CI). Robustness of the estimate was determined by sensitivity analysis. Heterogeneity was assessed by meta-regression analysis, subgroup analysis, and quality effects estimation. Publication bias was evaluated with a funnel plot and the Egger and Begg tests. Results: The summary effect for the association between housing stability and medication adherence was positive and significant (standardized mean difference = 0.15, 95% CI: 0.02 to 0.29). The association was slightly larger in the quality effects analysis (standardized mean difference = 0.20, 95% CI: 0.01 to 0.39). Sensitivity analysis disclosed that the association was robust at the P = 0.09 level. Results of the subgroup and meta-regression analyses were nonsignificant. Publication bias was not detected. Conclusion: Antiretroviral medication adherence is an increasing function of housing stability, but the magnitude of the effect is small. The finding challenges the view that unstable housing is incompatible with adherence and questions the potential benefit of deferring antiretroviral therapy initiation until the patient's housing circumstances are improved.

1 December 2003 in Cancer Causes & Control
Verified
Journal Article
Closed access
PDF file
RHRebecca A. Harris
Rebecca A. Harris
GCGang Chen
Gang Chen
WLWen Yao Lin
Wen Yao Lin
FSFu Min Shen
Fu Min Shen
WLW. Thomas London
W. Thomas London
AEAlison A. Evans
Alison A. Evans

2 July 2022 in Healthcare
Verified
Journal Article
Closed access
RHRebecca Arden Harris
Rebecca Arden Harris
KCKristen Campbell
Kristen Campbell
TCTara Calderbank
Tara Calderbank
PDPatrick Dooley
Patrick Dooley
HAHeather Aspero
Heather Aspero
MLMargaret Lowenstein
Margaret Lowenstein

1 April 2021 in Contemporary Clinical Trials
Verified
Journal Article
Closed access
RHRebecca Arden Harris
Rebecca Arden Harris
DMDavid S. Mandell
David S. Mandell
KKKyle M. Kampman
Kyle M. Kampman
YBYuhua Bao
Yuhua Bao
KCKristen Campbell
Kristen Campbell
HBHillary R. Bogner
Hillary R. Bogner